New targets for antivirals: The ribosomal A-site and the factors that interact with it

Virology

Volumn 300, Issue 1, 2002, Pages 60-70

  Goss Kinzy, Terri ^a,d   Harger, Jason W ^a,c   Carr Schmid, Anne ^a   Kwon, Jane ^a   Shastry, Mythili ^b   Justice, Michael ^b   Dinman, Jonathan D ^c  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Bldg 142   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Drugs; Elongation factors; Frameshifting; HIV; Ribosome; Translation; Virus

Indexed keywords

ANISOMYCIN; ANTIVIRUS AGENT; ELONGATION FACTOR; PREUSSIN; SORDARIN;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; ESCHERICHIA COLI; NONHUMAN; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RIBOSOMAL FRAMESHIFTING; SACCHAROMYCES CEREVISIAE; VIRUS PARTICLE;

DSRNA VIRUSES; EUKARYOTA;

EID: 0036383052     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1567     Document Type: Article

References (36)

1. al Karadaghi, S., Aevarsson, A., Garber, M., Zheltonosova, J., and Liljas, A. (1996). The structure of elongation factor G in complex with GDP: Conformational flexibility and nucleotide exchange. Structure 4, 555-565.
2. Andersen, G. R., Pedersen, L., Valente, L., Chatterjee, I., Kinzy, T. G., Kjeldgaard, M., and Nyborg, J. (2000). Structural basis for nucleotide exchange and competition with tRNA in the yeast elongation factor complex eEF1A:eEF1Balpha. Mol. Cell 6, 1261-1266.
3. Andersen, G. R., Valente, L., Pedersen, L., Kinzy, T. G., and Nyborg, J. (2001). Crystal structures of nucleotide exchange intermediates in the eEF1A-eEF1Balpha complex. Nat. Struct. Biol. 8, 531-534.
4. Brierley, I. (1995). Ribosomal frameshifting on viral RNAs. J. Gen. Virol. 76, 1885-1892.
5. Carr-Schmid, A., Durko, N., Cavallius, J., Merrick, W. C., and Kinzy, T. G. (1999). Mutations in a GTP-binding motif of eukaryotic elongation factor 1A reduce both translational fidelity and the requirement for nucleotide exchange. J. Biol. Chem. 274, 30297-30302.
6. Carr-Schmid, A., Valente, L., Loik, V. I., Williams, T., Starita, L. M., and Kinzy, T. G. (1999). Mutations in elongation factor 1beta, a guanine nucleotide exchange factor, enhance translational fidelity. Mol. Cell. Biol. 19, 5257-5266.
7. Carrasco, L., Barbacid, M., and Vazquez, D. (1973). The tricodermin group of antibiotics, inhibitors of peptide bond formation by eukaryotic ribosomes. Biochim. Biophys. Acta 312, 368-376.
8. Cavallius, J., and Merrick, W. C. (1998). Site-directed mutagenesis of yeast eEF1A. Viable mutants with altered nucleotide specificity. J. Biol. Chem. 273, 28752-28758.
9. Czworkowski, J., Wang, J., Steitz, T. A., and Moore, P. B. (1994). The crystal structure of elongation factor G complexed with GDP, at 2.7 Å resolution. EMBO J. 13, 3661-3668.
10. Dinman, J. D., Icho, T., and Wickner, R. B. (1991). A 31 ribosomal frameshift in a double-stranded RNA virus forms a gag-pol fusion protein. Proc. Natl. Acad. Sci. USA 88, 174-178.
11. Dinman, J. D., and Kinzy, T. G. (1997). Translational misreading: Mutations in translation elongation factor 1α differentially affect programmed ribosomal frameshifting and drug sensitivity. RNA 3, 870-881.
12. Dinman, J. D., Ruiz-Echevarria, M. J., Czaplinski, K., and Peltz, S. W. (1997). Peptidyl transferase inhibitors have antiviral properties by altering programmed -1 ribosomal frameshifting efficiencies: Development of model systems. Proc. Natl. Acad. Sci. USA 94, 6606-6611.
13. Dinman, J. D., Ruiz-Echevarria, M. J., and Peltz, S. W. (1998). Translating old drugs into new treatments: Identifying compounds that modulate programmed -1 ribosomal frameshifting and function as potential antiviral agents. Trends Biotechniques 16, 190-196.
14. Dinman, J. D., and Wickner, R. B. (1994). Translational maintenance of frame: Mutants of Saccharomyces cerevisiae with altered -1 ribosomal frameshifting efficiencies. Genetics 136, 75-86.
15. Dominguez, J. M., Gomez-Lorenzo, M. G., and Martin, J. J. (1999). Sordarin inhibits fungal protein synthesis by blocking translocation differently to fusidic acid. J. Biol. Chem. 274, 22423-22427.
16. Farabaugh, P. J. (1996). Programmed translational frameshifting. Microbiol. Rev. 60, 103-134.
17. Grollman, A. P. (1967). Inhibitors of protein biosynthesis. II. Mode of action of anisomycin. J. Biol. Chem. 242, 3226-3233.
18. Harger, J. W., Meskauskas, A., Nielsen, N., Justice, M. C., and Dinman, J. D. (2001). Ty1 retrotransposition and programmed -1 ribosomal frameshifting require the integrity of the protein synthetic translocation step. Virology 286, 216-224.
19. Ito, H., Fukuda, Y., Murata, K., and Kimura, A. (1983). Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153, 163-168.
20. Jacks, T., Madhani, H. D., Masiraz, F. R., and Varmus, H. E. (1988). Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region. Cell 55, 447-458.
21. Justice, M. C., Hsu, M. J., Tse, B., Ku, T., Balkovec, J., Schmatz, D., and Nielsen, J. (1998). Elongation factor 2 as a novel target for selective inhibition of fungal protein synthesis. J. Biol. Chem. 273, 3148-3151.
22. Kinzy, T. G., and Goldman, E. (2000). Nontranslational functions of components of the translational apparatus. In "Translational Control of Gene Expression" (N. Sonenberg, J. W. B. Hershey, and M. B. Mathews, Eds.), Vol. 39, pp. 973-997. Cold Spring Harbor Press, Cold Spring Harbor, NY.
23. Kinzy, T. G., and Woolford, J. L., Jr. (1995). Increased expression of Saccharomyces cerevisiae translation elongation factor 1 alpha bypasses the lethality of a TEF5 null allele encoding elongation factor 1 beta. Genetics 141, 481-489.
24. Koradi, R., Billeter, M., and Wuthrich, K. (1996). MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graph. 14, 51-32.
25. Liermann, R. T., Dinman, J. D., Sylvers, L. A., and Jackson, J. C. (2000). Improved purification of the double-stranded RNA from killer strains of yeast. Biotechniques 28, 64-65.
26. Merrick, W. C., and Nyborg, J. (2000). The protein biosynthesis elongation cycle. In "Translational Control of Gene Expression" (N. Sonenberg, J. W. B. Hershey, and M. B. Mathews, Eds.), Vol. 39, pp. 89-126. Cold Spring Harbor Press, Cold Spring Harbor, NY.
27. Meskauskas, A., and Dinman, J. D. (2001). Ribosomal protein L5 helps anchor peptidyl-tRNA to the P-site in Saccharomyces cerevisiae. RNA. 7, 1084-1096.
28. Nissen, P., Kjeldgaard, M., and Nyborg, J. (2000). Macromolecular mimicry. EMBO J. 19, 489-495.
29. Noller, H. F. (1997). Ribosomes and translation. Annu. Rev. Biochem. 66, 679-716.
30. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). "Molecular Cloning, A Laboratory Manual" (N. Ford, C. Nolan, and M. Ferguson, Eds.), Vol. 2(1), Cold Spring Harbor Press, Cold Spring Harbor, NY.
31. Sandbaken, M. G., and Culbertson, M. R. (1988). Mutations in elongation factor EF-13 affect the frequency of frameshifting and amino acid misincorporation in Saccharomyces cerevisiae. Genetics 120, 923-934.
32. Schwartz, R. E., Liesch, J., Hensens, O., Zitano, L., Honeycutt, S., Garrity, G., Fromtling, R. A., Onishi, J., and Monaghan, R. (1988). L-657398, a novel antifungal agent: Fermentation, isolation, structural elucidation and biological properties. J. Antibiot.(Tokyo) 41, 1774-1779.
33. Tumer, N. E., Parikh, B., Li, P., and Dinman, J. D. (1998). Pokeweed antiviral protein specifically inhibits Ty1 directed 31 ribosomal frameshifting and Ty1 retrotransposition in Saccharomyces cerevisiae. J. Virol. 72, 1036-1042.
34. UNAIDS/WHO Global AIDS Statistics. (2001). AIDS Care 13, 408.
35. Wickner, R. B. (1996). Prions and RNA viruses of Saccharomyces cerevisiae. Ann. Rev. Genet. 30, 109-139.
36. Wickner, R. B., and Leibowitz, M. J. (1976). Two chromosomal genes required for killing expression in killer strains of Saccharomyces cerevisiae. Genetics 82, 429-442.